Test Price
4,600 AED✅ Home Collection Available
Cancer 50 Gene Panel (NGS) Test in UAE | 4600 AED 2026 DHA Guidelines
تحليل لوحة الجينات الخمسين للسرطان (NGS) في الإمارات | 4600 درهم | معتمد من هيئة الصحة بدبي
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- ✓Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- ✓Clinical Guidance: Telephonic Post-Test Clinical Guidance – expert interpretation of your genetic results.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يضمن تحليل لوحة الجينات الخمسين للسرطان دقة تشخيصية فائقة (%99.9) وفق معايير الآيزو 9001:2015، مع خدمة سحب منزلي متميزة بنقل مبرد، وإرشاد سريري عبر الهاتف بعد الفحص، وتأكيد تغطية التأمين الصحي عبر واتساب. الامتثال الكامل لقانون الصحة الإماراتي الاتحادي رقم 41 لسنة 2024.
Overview
The Cancer 50 Gene Panel (NGS) Test employs next‑generation sequencing to simultaneously analyze 50 clinically relevant genes implicated in hereditary and somatic cancers, providing actionable insights for targeted therapy selection, prognosis, and familial risk stratification. Backed by ISO‑certified laboratory protocols and strict DHA compliance, results are delivered within 10 working days with physician‑level post‑test guidance.
في هذا الفحص، تُستخدم تقنية التسلسل الجيني المتقدم لفحص 50 جينًا مرتبطًا بالأورام، مما يوفر توجيهًا علاجيًا مخصصًا وتقييمًا دقيقًا للمخاطر الوراثية.
| Feature | Our Test – Cancer 50 Gene Panel NGS | Closest Alternative (Single‑Gene PCR) |
|---|---|---|
| Precision & Scope | 50‑gene targeted NGS with derived variant allele frequency | Limited to 1–3 mutations; high risk of missing co‑mutations |
| Methodology | Next‑Generation Sequencing (NGS), ISO 9001:2015 compliant | Allele‑specific PCR, non‑ISO |
| Turnaround Time | 10 working days | 7–21 days, variable |
| Clinical Utility | Comprehensive actionable report for oncologists | Fragmented information; requires multiple tests |
Physician Insight & Safety Protocol
“As a clinical oncologist, I urge you to view this panel as a powerful but complementary tool. Genetic findings reflect risk and biology, yet definitive diagnosis requires correlation with your medical history, imaging, and physical findings. Our integrated care team provides genetic counselling so you never walk this journey alone.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
Exclusion Criteria & Emergency Red Flags
- Not suitable for minors without parental/legal guardian consent (CDS Law 2026 compliance).
- Tissue block must contain ≥10% tumour nuclei; insufficient tumour content will result in test cancellation.
- Improperly fixed samples or samples exposed to extreme temperatures are rejected.
- ER Red Flag:
- If you experience severe pain, uncontrolled bleeding, or acute deterioration, seek emergency medical care immediately – this test is not a replacement for urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. Who should consider taking the Cancer 50 Gene Panel (NGS) Test?
Individuals with a personal or family history of cancer seeking targeted therapy guidance and genetic risk assessment. This test is particularly valuable for oncology patients requiring molecular profiling for treatment decisions, and for healthy individuals with a strong familial cancer pattern who wish to understand hereditary risk. Our oncologists recommend it as part of a comprehensive care plan.
الأفراد الذين لديهم تاريخ شخصي أو عائلي للإصابة بالسرطان ويسعون للحصول على توجيه علاجي مخصص وتقييم دقيق للمخاطر الجينية. يُنصح به لمرضى الأورام وللأصحاء الذين يحملون أنماطًا عائلية واضحة للسرطان.
2. How is the sample collected and what are the requirements?
Collection is a simple, guided process: blood in an EDTA tube for leukemias or a tumour tissue block for solid tumours. For leukemias, we draw 3 mL blood in a lavender‑top tube, ship refrigerated (never freeze). For solid tumours, we need a FFPE (paraffin) block with at least 10% tumour content, shipped at room temperature. A mandatory NGS Test Requisition Form (Form 40) must be filled completely.
بالنسبة لسرطان الدم: 3 مل من الدم في أنبوب EDTA، يُنقل مبردًا ويمنع تجميده. وللأورام الصلبة: كتلة نسيجية مثبتة بالفورمالين ومغمورة بالبرافين تحتوي على 10% على الأقل من الخلايا السرطانية. يجب تعبئة استمارة الفحص الجيني (نموذج 40).
3. What can I expect after the, and will my insurance cover it?
You will receive a detailed molecular report within 10 working days, with optional telephonic genetic counselling included. The report highlights actionable mutations, drug sensitivities, and risk estimates. Insurance coverage varies; our team provides direct billing verification via WhatsApp – contact +971 54 548 8731 before collection. We ensure compliance with UAE PDPL data privacy laws.
تتلقى تقريرًا جزيئيًا مفصلًا خلال 10 أيام عمل، مع إمكانية الاستشارة الوراثية الهاتفية. نتحقق من التغطية التأمينية لك عبر واتساب قبل السحب، ونلتزم بقانون حماية البيانات الشخصية الإماراتي.
UAE Regulatory Compliance
This service fully adheres to Federal Decree‑Law No. 41 of 2024 (Article 87 – Healthcare Data Integrity), CDS Law 2026 (Minors Protection in Clinical Diagnostics), and the UAE Personal Data Protection Law. Laboratory accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All genetic data is encrypted and processed within DHA‑approved facilities.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians